Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xishuangbanna Rainforest Pharmaceutical Co., Ltd. is a specialized pharmaceutical company based in Yunnan, China, focusing on the development and production of Traditional Chinese Medicines (TCM) and natural products derived from tropical flora. Originally established in 1989 as the Pharmaceutical Factory of the Xishuangbanna Tropical Botanical Garden under the Chinese Academy of Sciences, the company was restructured into its current form in 2001. Its flagship product is Longxuejie (Dragon's Blood), a TCM resin extract used for promoting blood circulation and healing traumatic injuries. The company's portfolio also includes treatments for cardiovascular health, liver support, and ophthalmology, such as Yixinshu Pills and Danshen Capsules. Rainforest Pharmaceutical operates GMP-certified manufacturing facilities and leverages the unique biodiversity of the Xishuangbanna region for its research and production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xishuangbanna Rainforest Pharmaceutical.